2m 2m 2m 2m 2m 2m 2m
Oramed (ORMP)
NASDAQ
$4.16+$0.09 (+2.21%)
Price as of Aug 03, 2026 7:32 AM EDT- $166.6MMarket Cap
- 105.93%1-Year Change
- BiotechnologyIndustry
Oramed (ORMP)
$4.16+$0.09 (+2.21%)
ORMP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.07 | ||
Change | -$0.05 (-1.21%) | ||
Open | $4.12 | ||
High | $4.13 | ||
Low | $3.94 | ||
Previous Close | $4.12 | ||
Volume | 208,669 | ||
30-Day Average Volume | 225,803 | ||
1-Week Change | 0.99% | ||
1-Month Change | -15.38% | ||
1-Year Change | 105.93% | ||
3-Year Change | 28.78% | ||
5-Year Change | -69.23% | ||
Fundamentals | |||
Shares Outstanding | 40.9M | ||
Total Assets | $268.8M | ||
Market Cap | $166.6M | ||
Enterprise Value | $166.6M | ||
Period: QTR TTM FY | |||
Revenue | $36.5M | ||
Net Income | $38.3M | ||
Free Cash Flow | -$2.9M | ||
EBIT | $49.4M | ||
EBITDA | $49.5M | ||
Net Working Capital | $57.6M | ||
EPS | $0.91 | ||
Enterprise Value/EBITDA | 3 | ||
Enterprise Value/Revenue | 5 | ||
P/B | 1 | ||
P/E | 4 | ||
PEG | 0 | ||
Price/Free Cash Flow | -57 | ||
Price/Operating Cash Flow | -57 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 55.28% | ||
Trailing Annual Dividend Yield | 6.14% | ||
Ex-Dividend Date | 01/16/2026 | ||
Last Split Factor | 1 : 12 | ||
Last Split Date | 01/23/2013 | ||
Earnings & Revenue
Annual Dividend Yield